Unibest

Pharmaceutical intermediates

Contezolid Intermediates

2 pharmaceutical intermediates for Contezolid. Indication: Complicated Skin and Skin Structure Infections.

提交项目All intermediates

About Contezolid

Originator
MicuRx
Indication
Complicated Skin and Skin Structure Infections
Approved Date
10/02/2018
NCE Patent
10/02/2028
DS/DP
06/02/2025

Available intermediates

2 intermediates currently listed for Contezolid. Request specifications, documentation or a quotation for any item below.

Contezolid intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
1112968-95-21112968-95-2//
Carbamic acid, 3-isoxazolyl-, 1,1-dimethylethyl ester (9CI)264600-97-7//

Other programs under C

Cabozantinib S-malateCalcipotriolCalcitriolCamlipixantCanagliflozinCangrelor TetrasodiumCapivasertib Capmatinib Hydrochloride

Building toward Contezolid?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →